MRI透明细胞可能性评分在肾脏肿块成像中的应用指南
小实性肾脏肿块中近20%为良性,透明细胞肾细胞癌是最常见且具侵袭性的亚型。透明细胞可能性评分系统基于主要特征(T2信号、皮髓质期强化、微观脂肪)和辅助特征(节段强化反转、动脉-延迟强化比、弥散受限)将肿块分为1-5分,并建议替代诊断及是否需活检,本文以病例示例指导读者应用该算法。
要点
- 透明细胞可能性评分系统提供1分(非常不可能)至5分(非常可能)的Likert评分,用于标准化分类小实性肾脏肿块。
- 主要特征包括T2信号强度、皮髓质期强化和微观脂肪;辅助特征包括节段强化反转、动脉-延迟强化比和弥散受限。
- 该算法还基于影像表现提示替代诊断,并旨在分层判断哪些患者可能受益于活检。
核心结论
- 透明细胞可能性评分系统为小实性肾脏肿块提供标准化框架,基于主要和辅助MRI特征分配透明细胞肾细胞癌可能性评分,并提示替代诊断及活检获益分层。
研究设计与样本
- 本文为用户指南,以病例示例引导读者评估透明细胞可能性评分算法的主要和辅助MRI特征,并讨论患者选择、成像参数、陷阱和未来发展方向。
关键影像表现/征象
- 主要特征包括T2信号强度、皮髓质期强化和微观脂肪的存在。
- 辅助特征包括节段强化反转、动脉-延迟强化比和弥散受限。
诊断标准与关键数值
- 透明细胞可能性评分系统提供1分(非常不可能)至5分(非常可能)的Likert评分,用于评估透明细胞肾细胞癌的可能性。
临床应用与阅片要点
- 放射科医生应使用透明细胞可能性评分算法评估小实性肾脏肿块的主要和辅助MRI特征以分配可能性评分。
- 该算法还基于影像表现提示替代诊断,并旨在分层判断哪些患者可能或不可能受益于活检。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Small solid renal masses (SRMs) are frequently detected at imaging. Nearly 20% are benign, making careful evaluation with MRI an important consideration before deciding on management. Clear cell renal cell carcinoma (ccRCC) is the most common renal cell carcinoma subtype with potentially aggressive behavior. Thus, confident identification of ccRCC imaging features is a critical task for the radiologist. Imaging features distinguishing ccRCC from other benign and malignant renal masses are based on major features (T2 signal intensity, corticomedullary phase enhancement, and the presence of microscopic fat) and ancillary features (segmental enhancement inversion, arterial-to-delayed enhancement ratio, and diffusion restriction). The clear cell likelihood score (ccLS) system was recently devised to provide a standardized framework for categorizing SRMs, offering a Likert score of the likelihood of ccRCC ranging from 1 (very unlikely) to 5 (very likely). Alternative diagnoses based on imaging appearance are also suggested by the algorithm. Furthermore, the ccLS system aims to stratify which patients may or may not benefit from biopsy. The authors use case examples to guide the reader through the evaluation of major and ancillary MRI features of the ccLS algorithm for assigning a likelihood score to an SRM. The authors also discuss patient selection, imaging parameters, pitfalls, and areas for future development. The goal is for radiologists to be better equipped to guide management and improve shared decision making between the patient and treating physician. © RSNA, 2023 Quiz questions for this article are available in the supplemental material. See the invited commentary by Pedrosa in this issue.
引用
- Shetty AS, Fraum TJ, Ballard DH, et al. Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide. Radiographics. 2023. PMID: 37319026. doi:10.1148/rg.220209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。